ClinicalTrials.gg
RecruitingNCT04276792JCOIN_TCUUpdated May 17, 2024

Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center

An interventional study of TCU Opioid-Treatment Linkage Model (O-TLM) in Addiction, Opioid, sponsored by Texas Christian University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-17.

Sponsored by Texas Christian University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Oct 2021; still recruiting 5 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,223 studies in Opioid-Related Disorders with a site in United States — 246 open to participants now, 316 under way, 18 of them phase 3. Opioid-Related Disorders · United States.

Planned enrollment
814th of 1,098
18 · median 56
Started
2021
with 104 others
No phase
571 of 1,223
133 open now
Primary completion
2026-04
later than 41 of 315 live
Registered
624th of 1,223
by date

Among the 1,223 studies in Opioid-Related Disorders with a site in United States, this one is the 814th largest by planned enrollment of the 1,098 interventional ones that give a count, is one of 105 that started in 2021, is one of 571 with no phase, reaches primary completion later than 41 of the 315 other live ones, and was the 624th registered.

Opioid-Related Disorders

1,476 studies on the registry are indexed under Opioid-Related Disorders; 293 are open to participants now.

Browse Opioid-Related Disorders studies →

Open to participants now

246 of the 1,223 studies in Opioid-Related Disorders with a site in United States are open now. Recruiting first, the newest first:

241 more — sign in →

All 246 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 213 Opioid-Related Disorders studies recruiting now, 123 (58%) set no upper age limit and 76 (36%) stop at 75 or younger; 14 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,223 studies in Opioid-Related Disorders with a site in United States, or all of them as a file.
02

Study summary

There are two study periods for the TCU JCOIN project. The primary aims of Study 1 (approved by the TCU IRB) are (1) to gather information from staff on the current treatment referral process within participating communities and (2) to learn about the existing interrelationships between medical and community behavioral health (CBH) providers. TCU IRB granted approval for Phase 1 on 11/07/19, approval number: 1920-60-AM1. Study 2 (under current review by the TCU IRB) includes recruitment across 18 community collaboration sites across 3 states; these communities will participate in the TCU Opioid-Treatment Linkage Model (O-TLM) protocol. The O-TLM is focused on best practices for improving screening, identifying and linking to MOUD providers, reducing stigma, and addressing other important factors that impact justice-involved individuals returning to their communities. Along with their agency records, information collected from justice-involved individuals within the target communities will be examined to assess O-TLM impact on improving public health and public safety outcomes. Furthermore, stakeholder staff across community organizations, including criminal justice and treatment agencies, will be asked to complete surveys on the O-TLM regarding its acceptability and adoption, as well as on best training strategies.

03

Conditions studied

  • Addiction, Opioid
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • client level participant eligibility includes having a history of opioid use or at risk for opioid use; being released to a participating community while under supervision
  • staff level participant eligibility includes being a key member of a participating community and involved in the service assessment and referral process of justice-involved individuals.

Exclusion criteria

Exclusion Criteria:

  • no history of opioid use or being at risk of opioid use; not being released to a participating community.
  • staff level participant exclusion criteria include not being a key member of a participating community and not being involved in the service assessment and referral process of justice-involved individuals.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
18 participants (estimated)

Study arms

  • Experimental
    Horizontal implementation approach

    The Horizontal implementation approach of the O-TLM intervention is accompanied by facilitated collaboration between Criminal Justice and Community Behavioral Health systems. Direct involvement of stakeholders with differing perspectives and buy-in from agency leadership and policymakers are key elements. The Horizontal approach involves first developing a prototype (including how to modify existing practices, overcome implementation barriers, and manage roles and responsibilities) that are tested and refined before being rolled out systematically to other units within an agency.

    Behavioral: TCU Opioid-Treatment Linkage Model (O-TLM)

  • Active comparator
    Vertical implementation approach

    The Vertical implementation approach of the O-TLM intervention relies on the traditional criminal justice system's typical use of a hierarchical structure and the use of a top-down implementation approach (i.e., administrative orders) for directing change. Top-down regulatory and policy changes are viewed as vital levers for driving system change.

    Behavioral: TCU Opioid-Treatment Linkage Model (O-TLM)

Interventions

  • BehavioralTCU Opioid-Treatment Linkage Model (O-TLM)

    The O-TLM is focused on best practices for improving screening, identifying and linking to MOUD providers, reducing stigma, and addressing other important factors that impact justice-involved individuals returning to their communities.

06

What researchers measure

Primary outcomes

  1. Public Health assessed by decrease in days and amount of illicit drug use, including opioids

    decreases in days and amount of illicit drug use, including opioids assessed through client interviews using the timeline follow-back method

    Time frame: 6 months and 12 months post-release

  2. Public Safety as assessed through reduction in rearrest rates

    reductions in rearrest rates measured through justice and department of pubic safety records

    Time frame: 6 months and 12 months post-release

  3. Increase in Access to Services

    referral rate increase as self-reported through client interviews and provided through justice records

    Time frame: 6 months and 12 months post-release

  4. Increase in Retention in Services

    appointments kept as self-reported through client interviews and provided through justice and provider records

    Time frame: 6 months and 12 months post-release

Secondary outcomes

  1. Systems Impact as assessed through improved intervention attitudes

    staff attitudes of intervention acceptability as assessed through survey

    Time frame: 6 and 12 months post implementation start

  2. Systems Impact as assessed through intervention cost

    accumulated cost of intervention

    Time frame: 6 and 12 months post implementation start

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Will adhere to NIH JCOIN approved plan

Supporting information: Study protocol, Informed consent form

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for Apr 2026, 54 months after the start.

Of 465 non-industry interventional studies with no phase under Opioid-Related Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 47. This study's planned 54 months is above that.

Counting every sponsor, half of 496 studies reached it within 29 months; a quarter within 13 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2020
First posted
Feb 19, 2020
StartActual
Oct 7, 2021
Primary completionEst.
Apr 30, 2026
CompletionEst.
Apr 30, 2026
Last update
May 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04276792
Lead sponsor
Texas Christian University
Responsible party
DanicaKnight (Associate Professor, Texas Christian University) — Principal investigator
First posted
Feb 19, 2020
Start date
Oct 7, 2021
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
May 17, 2024

Study contacts

Jennifer Becan, PhD
Contact
j.becan@tcu.edu
18172576518
Danica K Knight, PhD
principal investigator · Texas Christian University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion